Applications of molecular MRI and optical imaging in cancer

Marie-France Penet1, Maria Mikhaylova, Cong Li

  • 1JHU ICMIC Program, The Russell H Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Insights

Chemistry and imaging innovations are revolutionizing cancer treatment. Novel imaging probes and targeted drug delivery systems show promise for eliminating cancer cells while minimizing damage to healthy tissues.

Area of Science:

  • Molecular imaging
  • Cancer research
  • Chemistry

Background:

  • Cancer cells evade destruction due to drug resistance and toxicity.
  • Poor drug delivery and damage to normal tissues are major challenges in cancer therapy.
  • Molecular-functional imaging offers new strategies for cancer treatment.

Purpose of the Study:

  • To demonstrate how integrating imaging with novel probes can facilitate successful cancer treatment.
  • To highlight advances in molecular-functional imaging at the interface of chemistry and imaging.
  • To showcase novel imaging probes and image-guided platforms for cancer therapy.

Main Methods:

  • Development of novel imaging probes reporting on molecular pathways and tumor micro-environment.
  • Utilizing image-guided platforms like nanoparticles and nanovesicles for targeted drug delivery.
  • Application of Magnetic Resonance Imaging (MRI) and optical imaging techniques.

Main Results:

  • Novel probes provide insights into molecular pathways and treatment response.
  • Nanoparticles and nanovesicles enable targeted delivery of therapeutic agents.
  • Integrated imaging approaches show potential for effective cancer treatment with reduced toxicity.

Conclusions:

  • Advances in chemistry and imaging are crucial for developing effective cancer therapies.
  • Molecular-functional imaging combined with targeted delivery offers a promising strategy to overcome drug resistance and toxicity.
  • This integrated approach facilitates the successful treatment of complex cancers.